Evaluating Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)...

σε πρόσθεσε στο Wellness

2025-12-08 16:44:35 -

Evaluating Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Size and Future Expansion Potential

The considerable Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Size is directly proportional to the high cost of its primary treatment modality—immunoglobulin therapy—and the chronic, lifelong need for treatment among the diagnosed patient population. CIDP is a rare disorder, yet the high average annual cost of therapy for each patient ensures a multi-billion...

0 Σχόλια 0 Μοιράστηκε 467 Views 0 Προεπισκόπηση